Automated Nucleic Acid Extraction Devices Market Expected to Achieve 14.1% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Automated Nucleic Acid Extraction Devices Market Size By 2025?
The market size of automated devices for extracting nucleic acid has seen accelerated growth in the past few years. It is projected to expand from $5.93 billion in the year 2024 to $6.58 billion in 2025, marking a compound annual growth rate (CAGR) of 10.9%. Factors that contributed to this historic expansion include a rising demand for molecular diagnostics, heightened consciousness about the advantages of automation, the pharmaceutical and biotechnology industries' growth, government efforts to support molecular diagnostics, and an increased interest in these particular types of diagnostics.

How Big Is the Automated Nucleic Acid Extraction Devices Market Size Expected to Grow by 2029?
The market size of automated nucleic acid extraction devices is anticipated to expand significantly in the forthcoming years. It is projected to reach $11.15 billion by 2029, with a compound annual growth rate (CAGR) of 14.1%. The growth during the prediction period can be linked to the escalating demand for personalized medicine, a rising focus on precision medicine, an upsurge in demand for automation, point-of-care testing, and integration with next-generation sequencing. The forecast period is expected to witness significant trends such as advanced technologies, increased demand for molecular diagnostics, shrinkage of automated systems, point-of-care testing, and inclusion of artificial intelligence (AI) and data analytics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automated-nucleic-acid-extraction-devices-global-market-report

Which Key Market Drivers Powering Automated Nucleic Acid Extraction Devices Market Expansion and Growth?
The expansion of the automated nucleic acid extraction devices market is set to be fueled in the future by an increasing volume of research and development endeavours. These are efforts conducted by companies to collect and analyze market data before initiating the developmental phase for introducing new products and services and enhancing the company's profitability. Automated nucleic acid extraction devices play a key role within these research and development activities, particularly in clinical diagnosis, biological analysis, and environmental monitoring, thereby enhancing the company's capacity to create innovative solutions. For example, the World Health Organization (WHO), a specialized health agency based in Switzerland, reported in July 2022 that the percentage of nations with the ability to perform genomic surveillance had increased from 54% to 68% between March 2021 and January 2022 due to the investments made amid the COVID-19 pandemic. Consequently, the uptake in research and development activities is contributing significantly to the growth trajectory of the automated nucleic acid extraction devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9421&type=smp

Which Emerging Trends Are Transforming the Automated Nucleic Acid Extraction Devices Market in 2025?
The trend of product innovation is increasing in prominence in the automated nucleic acid extraction device market. To maintain their foothold in the market, leading companies are launching groundbreaking products. Aurora Biomed, a Canada-based automated medical equipment producer, exemplified this in August 2022 when they unveiled the VERSA NAP Automated DNA Extraction Systems, also known as the automated nucleic acid extraction system. This system, which can handle 1-96 samples simultaneously, streamlines DNA and RNA extractions as well as related purification protocols. The integrated plate grippers and transporters enable it to isolate high-quality, pure DNA or RNA, yielding strong nucleic acid results.

What Are the Emerging Segments in the Automated Nucleic Acid Extraction Devices Market?
The automated nucleic acid extraction devices market covered in this report is segmented -

1) By Type: Instruments, Kits, Consumables
2) By Product: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes

Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9421&type=smp

Who Are the Global Leaders in the Automated Nucleic Acid Extraction Devices Market?
Major companies operating in the automated nucleic acid extraction devices market include QIAGEN NV, PerkinElmer Inc., F. Hoffmann-La Roche AG, Die Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Illumina Inc., Tecan Trading AG, Merck Co. & KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Tianlong-Xi'an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Tecan Group Ltd., Beckman CoulterInc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, BioChain Institute Inc., Biomatrica Inc., Corbett Life Science Pty Ltd., Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., LGC Biosearch Technologies, MicroGEM International Company, Norgen Biotek Corp.

Which are the Top Profitable Regional Markets for the Automated Nucleic Acid Extraction Devices Industry?
North America was the largest region in the automated nucleic acid extraction devices market in 2024. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9421

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.